Sign in
Active, not recruitingPhase 1

Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases

Key facts

Who runs it
Case Comprehensive Cancer Center
Where
Cleveland, United StatesSee the site
Trial code
Status
Active, not recruiting
Phase
Phase 1
People taking part
33 people enrolled
Started
2 Jul 2013
Ended
Aug 2025
Type of study
Interventional
Treatments tested
  • stereotactic radiosurgery
  • quality-of-life assessment
  • cognitive assessment
Record updated
20 July 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (15)Hide the full registry criteria

Who can take part

  • Any patient undergoing SRS for brain metastases
  • Lesions to be treated under this protocol must be > 2 cm, but =< 4.0 cm in diameter
  • Patients may have had prior therapy including:; Whole brain radiation therapy (WBRT) > 3 months ago; SRS to other brain metastases
  • Patients with newly diagnosed brain metastases are eligible as long as they are not planned for WBRT upfront
  • Any primary is eligible with exception of small cell lung cancer, lymphoma, and germ cell histologies
  • Patient must be able to provide written informed consent

Who cannot take part

  • Patients receiving SRS to resection bed
  • Planned concurrent WBRT
  • Small cell lung cancer, lymphoma, and germ cell histologies
  • Leptomeningeal metastases
  • Inability to participate in study activities due to physical or mental limitations
  • Inability or unwillingness to return for all the required follow-up visits
  • Conformality index 2.0 or less cannot be achieved, or homogeneity index is > 2.0
  • Unable to deliver 10 Gray (Gy) or less to optic nerve/chiasm
  • Brainstem location is excluded from this study

Where in United States

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer CenterCleveland, United States

About the trial

What the trial wants to find out

This phase I/II trial studies the side effects and the best dose of stereotactic radiosurgery and to see how well it works in treating patients with large brain metastases. Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue.

The group in the trial

  • Treatment (SRS)Treatment being tested

    Patients undergo SRS guided by CT and MRI.

    Treatment: stereotactic radiosurgery, quality-of-life assessment, and cognitive assessment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dose Escalation for Larger Brain Metastases: Phase I/II Study
Record updated
20 July 2025